Hypoxia is a major cause of radiation resistance, which may predispose to local recurrence after radiation therapy. While hypoxia increases tumor cell survival after radiation exposure because there is less oxygen to oxidize damaged DNA, it remains unclear whether signaling pathways triggered by hypoxia contribute to radiation resistance. For example, intratumoral hypoxia can increase hypoxia inducible factor 1 alpha (HIF-1a), which may regulate pathways that contribute to radiation sensitization or radiation resistance. To clarify the role of HIF-1a in regulating tumor response to radiation, we generated a novel genetically engineered mouse model of soft tissue sarcoma with an intact or deleted HIF-1a. Deletion of HIF-1a sensitized primary sarcomas to radiation exposure in vivo. Moreover, cell lines derived from primary sarcomas lacking HIF-1a, or in which HIF-1a was knocked down, had decreased clonogenic survival in vitro, demonstrating that HIF1a can promote radiation resistance in a cell autonomous manner. In HIF-1a-intact and -deleted sarcoma cells, radiationinduced reactive oxygen species, DNA damage repair and activation of autophagy were similar. However, sarcoma cells lacking HIF-1a had impaired mitochondrial biogenesis and metabolic response after irradiation, which might contribute to radiation resistance. These results show that HIF-1a promotes radiation resistance in a cell autonomous manner. Ó 2015 by
INTRODUCTION
Tissue hypoxia, defined by physiologically low oxygen availability, is one of the most important cellular stresses due to the vital role of oxygen as the final electron acceptor in the electron transport chain. Tissue hypoxia is observed in solid tumors (1, 2) , and has long been recognized to negatively affect solid tumor response to radiation therapy. For example, animal experiments in the mid-20th century showed that increasing oxygen concentration in the tumor by placing the animals in hyperbaric high-pressure oxygen chambers during radiation exposure increased both tumor and normal tissue sensitivity to radiation (3) (4) (5) . Moreover, a number of clinical trials have been conducted in which cancer patients were treated with concurrent radiation therapy and either hyperbaric oxygen or other modifiers of hypoxia such as carbogennicotinamide or radiobiologic mimics of oxygen such as metronidazole. A 2007 meta-analysis of all 61 published clinical trials to date revealed that 87% of the studies showed that modifiers of tumor hypoxia during radiation therapy resulted in either improvement in locoregional control, overall survival or both (6) . Interestingly, in a phase III trial of advanced head and neck cancer patients randomized to chemo-radiation with or without the hypoxic cytotoxin tirapazamine, in the subset of patients that had hypoxia imaging by PET prior to treatment, only the patients with hypoxic tumors benefited from tirapazamine (7) . One mechanism that contributes to the oxygen enhancement ratio is that molecular oxygen can interact with radiation-induced radicals in the cell to form adducts in carbohydrates, proteins or lipids. Most importantly, radiation induces oxygen-DNA adducts that are difficult or impossible to repair, which can lead to cell death.
In addition to acting as an acceptor of electrons from ionized molecules, oxygen can also regulate radiation response by altering cellular gene expression via hypoxia inducible factors (HIFs) (8) . HIFs are heterodimeric basic helix-loop-helix Per-Arnt-Sim (bHLH-PAS) family transcription factors composed of an alpha and beta subunit. When dimerized, HIFs bind to hypoxia responsive elements (HRE) in the promoters or enhancers of target genes. The alpha subunit of HIF is regulated by oxygen tension. At high oxygen levels (.8-10%), HIF alpha subunits become less abundant at the protein level due to prolyl hydroxylasemediated degradation, which for HIF-1a decreases the halflife to 5-10 min despite continued transcription of the HIF-1a mRNA. Under hypoxia, the alpha subunits are stabilized and no longer degraded, so that HIF proteins are able to rapidly alter pathways such as cellular metabolism (9) , angiogenesis (10) and survival (11) . Although hypoxia in tumors activates HIF-1a, it is not clear whether activation of HIF-1a signaling contributes to radiation resistance in primary cancers.
Previous studies investigating the role of HIF-1a in tumor response to radiation therapy using transplanted tumor model systems suggest that HIF-1a may both promote radiation resistance and radiation sensitivity. For example, HIF-1a can sensitize tumor cells to radiation by promoting ATP metabolism, proliferation and p53 activation, but HIF-1a can also cause resistance to radiation therapy by promoting endothelial cell survival (12) . Other studies have suggested that HIF-1a promotes resistance to radiation by increasing the transcription of genes that inhibit apoptosis (13) . However, to our knowledge the role of a HIF-1a in mediating tumor response to radiation exposure in a primary mouse tumor model has not been performed. In this current study, we generated a novel primary mouse model of soft tissue sarcoma to dissect the role of HIF-1a function within tumor cells in the response of primary cancers to radiation. We show that deletion of HIF-1a in this sarcoma model sensitizes tumor cells to radiation in a cell-autonomous manner.
METHODS

Generation of the Mouse Model of Soft Tissue Sarcoma
All animal experiments were performed according to protocols approved by the Duke University Institutional Animal Care and Use Committee. Mouse models of soft tissue sarcoma were generated in a mixed 129/SVJae and C57BL/6 background using a combination of previously described alleles: Pax7
Cre-ER-T2 (provided by Chen-Ming Fan, Carnegie Institution for Science, Baltimore, MD) (20) (46) and ROSA26 mTmG (47) (Jackson Laboratory, Bar Harbor, ME). (Z)-4-hydroxytamoxifen (Sigma-Aldricht LLC, St. Louis, MO), which is referred to as 4-OHT, was first dissolved in 100% ethanol at a concentration of 250 mg/ml, and then diluted with corn oil (Sigma-Aldrich) to a final working solution concentration of 25 mg/ ml. Primary mouse soft tissue sarcomas were generated in the mouse hind limb by intramuscular (im) injection of 20 ll 4-OHT working solution with a 27.5 gauge insulin syringe (Terumot Medical Corp., Elkton, MD).
Image-Guided Fractionated Radiation Exposure
Irradiation was performed on the tumor-bearing hind limbs of mice, modeling radiation therapy, when tumors reached 200 mm 3 as measured by calipers using the formula, V ¼ (pi*x*y*z)/6, where V defines volume, and x, y and z define length, width and height of the tumor. At the time of exposure, each animal was placed on the irradiation stage in the X-RAD 225Cx micro-CT/micro-irradiator (Precision X-ray Inc., North Bradford, CT). Continuous 2% isoflurane anesthesia was delivered by nose cone at a rate of 2 L of oxygen per min. Hind limbs of mice were irradiated using a 40 3 40 mm square collimator and fluoroscopy-guided radiation delivered at 225 kVp and 13 mA using two opposed fields, as previously described (48) . Subsequent fractions were delivered at 24 h intervals. Mice were followed for tumor recurrence as defined by tumor growth exceeding 33 the initial volume measured on day 1 of exposure.
Injection of EF5 and Hoechst 33342
Tumor-bearing mice were anesthetized by intraperitoneal (ip) injection of pentobarbital at 85 mg/kg. The hypoxia marker EF5 (Cameron Koch, University of Pennsylvania, Philadelphia, PA) was delivered by ip injection at 26.5 ml/kg from a 10 mM stock solution in saline. One minute before surgical removal of the tumors, tail veins of anesthetized animals were injected with 100 ll of 20 mg/ml Hoechst 33342 (Sigma-Aldrich) diluted in saline. Tumors were surgically removed from deeply anesthetized animals and snap frozen in liquid nitrogen.
Tumor Cell Isolation and Culture
Tumor tissue from untreated sarcomas was removed from mice and digested with 5 mg/ml collagenase IV (Worthington Biochemical Corp., Lakewood, NJ), 2.5 U/ml dispase (BD Biosciences, San Jose, CA) and 0.05% trypsin (Life Technologies, Grand Island, NY) at 378C for 40 min. The resulting mixture was strained through a 70 lm filter (BD Biosciences), and filtered cells were resuspended in culture media consisting of modified Eagle media (MEM; Life Technologies) with 10% fetal bovine serum (FBS; Sigma-Aldrich), 5.6 mM glucose and 0.6 mM GlutaMAXe (Life Technologies). Cells were serially passaged to deplete stromal (nontumor) cells. Tumor cell purity was verified with 50 cycles of polymerase chain reaction (PCR) of bulk cell DNA for the presence of wild-type and conditionally deleted alleles. Cell counting was performed using the Cellometert Auto 2000 counter (Nexcelom Bioscience LLC, Lawrence, MA). For hypoxic tissue culture, cells were placed in the InvivO 2 500 (Baker Ruskinn, Sanford, ME) hypoxia chamber with 0.5% O 2 and 5% CO 2 for 24 h. For in vitro exposure, cells were irradiated in culture plates either with an X-RAD 320 irradiator (Precision X-ray Inc.) at 320 kVp and 10 mA, except for the DNA end-joining repair assay, which utilized an X-RAD 160 (Precision X-ray Inc.) at 160 kVp and 18 mA, for the indicated doses. Irradiated cells were returned to the culture chamber for the indicated times. For shRNA knockdown, lentiviral particles were generated using Hif-1a shRNA (TRCN000054450; Thermoe Scientific, Inc., Boston, MA) and MISSIONe Lentiviral Packaging Mix (SHP001; Sigma-Aldrich) in 293T cells per manufacturer's specifications. P7NP sarcoma cells were transduced with polybrene (4 lg /ml) and supernatant media containing lentiviral particles, and clones were positively selected in puromycin (3 lg /ml) for 10 days prior to assessment of HIF-1a knockdown efficiency by hypoxic culture and Western blot.
PCR, qRT-PCR
DNA was isolated using the DNeasy Blood and Tissue Kit (QIAGENt, Valencia, CA) and PCR experiments were performed with a C1000 Touche Thermal Cycler (Bio-Rad Laboratories Inc., Hercules, CA). RNA was isolated using the RNeasy Mini Kit (QIAGEN), cDNA was synthesized using the iScripte cDNA Synthesis Kit (Bio-Rad) and qPCR experiments were performed with an iCycler (Bio-Rad). Nucleic acid concentrations were measured using NanoDrop 1000.
Primers used are as follows:
Western Blot, Immunofluorescence, Immunohistochemistry and Fluorescence-Activated Cell Sorting
For Western blots, whole cell lysates were generated by direct application of 23 Laemmli buffer (Bio-Rad) with b-mercaptoethanol (Sigma-Aldrich) onto the cell monolayers. Nuclear extracts were generated using the NE-PER kit (Piercee Biotechnology, Rockford, IL) per the manufacturer's instructions. Protein lysates from cells treated by hypoxia were collected directly in the hypoxia chamber with 800 lM deferoxamine (Sigma-Aldrich) added to all lysis buffers. Protein concentrations were measured using either the BCA protein assay kit (Pierce) or the 660 nm protein assay kit (Pierce). Protein lysates were electrophoresed on mini-PROTEANt pre-cast gels (BioRad) in the mini-PROTEAN tetra cell system (Bio-Rad) and transferred onto PVDF membranes. For protein carbonylation blots, experiments were performed using the OxyBlote protein oxidation detection kit (Millipore, Billerica, MA) per the manufacturer's instructions. For the frozen histological sections, 10 lm sections were generated using a Leica cryostat (Buffalo Grove, IL) and stored unfixed at À808C. For the paraffin histological section, tumor specimens were fixed in 10% formalin and 70% EtOH. After paraffin embedding, 4 lm sections were generated using a manual rotary microtome (Leica)
Immunohistochemistry on paraffin embedded tissues was performed using ready-to-use target retrieval solution (Dako, Glostrup, Denmark), antibody diluent (Dako), the VECTASTAINt Elite ABC Kit (Vector Laboratories, Burlingame, CA) and 3,3 0 -diaminobenzidine tetrahydrochloride (Sigma-Aldrich). For frozen sections, unfixed slides were first fixed in 4% paraformaldehyde, and then immunohistochemistry was performed as described above except without the use of target retrieval solution. For immunofluorescence experiments, frozen sections were obtained as described above and stained as previously described (48) . Images were captured either with a Leica DM5500B microscope using Leica Application Suite software, an Axioskop 2 plus microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY) with computerized scanning stage (Märzhäuser Wetzlar GmbH & Co., Wetzlar, Germany), or a custom Axioskop microscope (Carl Zeiss) in black box with a 16 bit CCD camera with photon counting capabilities (Andor Technology, South Windsor, CT). Image analyses were performed using ImageJ software (National Institutes of Health, Bethesda, MD). For fluorescence-activated cell sorting, cells were resuspended in phosphate buffered saline (PBS) with 2% FBS in a single cell suspension in 5 ml polystyrene round-bottom tubes (BD Biosciences). Cells were sorted or analyzed with a FACSVantagee cell sorter (BD Biosciences). Final analyses on the raw data were performed using FlowJo software (FlowJo LLC, Ashland, OR). Antibodies and other reagents used are listed in Supplementary Table S1 (http://dx.doi.org/10.1667/RR14016.1.S1).
Tissue Microarrays
Use of human sarcoma tissue microarray was approved by the Institutional Review Board at Duke University Medical Center. Tissue microarrays were generated by the Radiation Therapy Oncology Group (RTOG) using pre-and post-treatment biopsies of soft tissue sarcomas from Massachusetts General Hospital. In total, there were 23 evaluable cases with 8 samples of paired pre-and post-treatment biopsies, 1 sample of pre-treatment biopsy only and 14 samples of post-treatment only. Tissue microarrays were stained for HIF-1a as above and scored semi-quantitatively on a scale of 0-3þ by a sarcoma pathologist (DMC) blinded to sample identification and treatment. A median score was used for each tumor, as each sample was present in triplicate on the tissue microarray. Scores were correlated with preand post-treatment status using the Fisher's exact test.
Targeted Metabolite Analysis
Adherent cells were scraped and pelleted in ice-cold PBS. Cell pellets were resuspended in ice-cold deionized water containing 0.6% formic acid. Acetonitrile was added to the resuspended cell solution in a 1:1 ratio. Samples were stored in À808C and were analyzed as previously described (49) .
For the extracellular lactate assay, culture media at indicated time points were filtered through 10 kD polyethersulfone spin columns (BioVision Inc., Milpitas, CA), snap frozen in liquid nitrogen, and stored at À808C. Analysis was performed using a commercially available lactate colorimetric assay kit (BioVision) per manufacturer's instructions.
Seahorse Analysis
Adherent cells were grown and treated in Seahorse 24-well plates (Seahorse Bioscience, North Billerica, MA). Twenty-four hours prior to experimentation, 1 ml calibration solution was placed in each well of the sensor cartridge plate, and the sensor cartridge immersed in calibration solution was incubated at 378C overnight. Prior to experimentation, cell media was changed to 600 ll XF assay media (Seahorse Bioscience) and incubated at 378C for at least 60 min, and 30 ll of 203 prewarmed compounds were loaded into each of the 4 ports per well in the sensor cartridge, resulting in the following final drug concentrations: 20 mM 2-deoxyglucose (2-DG); 1 lM oligomycin (Oligo); 0.5 lM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP); 1.5 lM antimycin A (Anti A); and 0.75 lM rotenone (Rot). The sensor cartridge and cells were placed in the Seahorse XF24 analyzer for oxygen consumption and extracellular acidification readings.
DNA End-Joining Repair Assay
The comet assay was performed using the Trevigent CometAssayt kit (Gaithersburg, MD). Prior to irradiation, cells were cultured for 24 h in complete media substituted with 0.1% FBS to stimulate G 1 arrest. At the indicated time after 10 Gy irradiation, adherent cells were scraped and pelleted in ice-cold PBS. Cell pellets were resuspended in ice-cold PBS at a concentration of 1 3 10 5 cells/ml, after which 25 ll of cell suspension was added to 250 ll low-melting point agarose, and 50 ll of cells in agarose was added and solidified on each well of the slide. Cells in solidified agarose on comet assay slides were lysed at 48C in 13 lysis buffer for 1 h, followed by neutral buffer for 30 min. Slides were electrophoresed for 45 min at 21V, and DNA was precipitated in DNA precipitation buffer for 30 min at room temperature after electrophoresis. Slides were then fixed in 70% ethanol for 30 min and dried overnight prior to DNA staining with SYBR Gold. Images were taken by epifluorescence microscopy and DNA tails were measured using the Trevigen software package.
RESULTS
Human Soft Tissue Sarcomas Upregulate HIF-1a after Chemo-Radiation Therapy
To examine whether HIF-1a levels change in human soft tissue sarcomas in response to radiation, we obtained a tissue microarray of soft tissue sarcoma samples that included biopsies before exposure or at the time of surgical resection after interdigitated neoadjuvant MAID chemo-therapy (mesna, doxorubicin, ifosfamide and dacarbazine) and 44 Gy irradiation (14) . HIF-1a immunostaining was performed on the tissue microarray and the staining intensity was scored for HIF-1a by a sarcoma pathologist blinded to the timing of chemo-radiation treatment relative to the biopsy. An increase in HIF-1a nuclear intensity and quantity of HIF-1a-positive nuclei in tumor cells were observed in samples after chemo-radiation treatment ( 
Generation and Characterization of a Novel Mouse Model of Soft Tissue Sarcoma
We previously showed that some tumors generated by injection of tamoxifen into Pax7
FL/FL mice resembled human rhabdomyosarcoma (RMS) (15, 16) . Because NRAS is more commonly mutated in human RMS than KRAS (17-19), we generated Pax7
; ROSA26 mTmG/mTmG (P7NP) mice to model mutations that more frequently occur in human RMS. The ROSA26 mTmG allele is a fluorescent reporter allele that in the absence of Cre recombinase expresses membranetagged red fluorescent protein (tdTomato) from the ubiquitous ROSA26 promoter, but in the presence of Cre recombinase deletes tdTomato to express membrane-tagged green fluorescent protein (eGFP). In this model, the expression of the fusion protein CreER-T2 is driven by the endogenous Pax7 promoter, which in the adult mouse is expressed in skeletal muscle satellite cells (20) . Exposure of CreER-T2 to 4-hydroxytamoxifen (4-OHT), which is the active metabolite of tamoxifen, leads to the accumulation of CreER-T2 in the nucleus and recombination of loxP flanked alleles to activate expression of the Nras G12D oncogene, delete both alleles of p53, delete tdTomato and express eGFP. Therefore, the fluorescent proteins will mark the tumor cells that have undergone Cre-mediated recombination green, but the normal cells of the stroma that have not undergone Cre-mediated recombination will remain red.
Intramuscular hind limb injection of 4-OHT in the Pax7
CreER-T2/þ ; Nras
; ROSA26 mTmG/mTmG mice caused sarcomas to form at the site of injection after 1-3 months with 100% penetrance (Fig. 2A) .
Consistent with previous findings from our group, sarcomas derived from adult skeletal muscle satellite cells with activation of oncogenic RAS and deletion of p53 fall in a spectrum of histological subtypes ranging from undifferentiated pleomorphic sarcoma (UPS, Fig. 2B ) to RMS (Fig.  2C) . Whereas UPS does not show any specific line of differentiation and is a diagnosis of exclusion, RMS contains rhabdomyoblasts, which are cells with eosinophilic cytoplasm and eccentric nuclei (21) . Regardless of histological subtype, these sarcomas showed regions of localized HIF-1a staining by immunohistochemistry (Fig. 2D ) that suggested the presence of tumor hypoxia. The presence of hypoxic regions and their relationship to vascular perfusion within the tumor were further examined with EF5 ( Fig. 2E) and Hoechst 33342 perfusion (Fig. 2F) Human soft tissue sarcomas accumulated nuclear HIF-1a after interdigitated chemo-radiation therapy. Panels A-C: Formalin-fixed paraffin embedded (FFPE) tissue microarray from human soft tissue sarcoma biopsies prior to and after chemo-radiation therapy was stained with antibody against HIF-1a. The HIF-1a-stained tissue microarray was subsequently read by a pathologist blinded to the samples and scored based on HIF-1a staining intensity. Panel A: HIF-1a nuclear accumulation score increased significantly with interdigitated chemo-radiation therapy using the Fisher's exact test. Panels B and C: Paired pre-and postirradiated human soft tissue sarcoma biopsies stained with an antibody to HIF-1a. Scale bar ¼ 50 lm. *P , 0.05. FL alleles were efficiently recombined (1-loxP) at the genomic level (Fig. 3A) . qRT-PCR was performed using exon 2-specific primers for Hif-1a on cDNA synthesized from RNA extracted from P7NP and P7NPH1 tumor cells, which confirmed the lack of Hif-1a transcript in P7NPH1 tumor cells (Fig. 3B) . Finally, P7NP and P7NPH1 tumor cells were cultured under hypoxic conditions (0.5% oxygen) for 16 h and nuclear lysates were extracted. Western blot of those lysates confirmed lack of HIF-1a protein accumulation in P7NPH1 cells after hypoxic stimulus (Fig. 3C ). Since HIF-1a was ablated at the start of tumorigenesis, this could potentially modify tumor subtype, such as tumor differentiation status. Therefore, tumors were collected from P7NP and P7NPH1 mice and hematoxylin and eosin (H&E) stained sections were evaluated by a sarcoma pathologist blinded to genotype. Regardless of HIF-1a status, ;60% of the tumors generated resembled UPS by H&E staining, while ;40% of the tumors generated resembled RMS by H&E staining (Fig. 3D-H) .
To determine how HIF-1a may affect tumor microenvironmental hypoxia in primary sarcomas generated in P7NP and P7NPH1 mice, whole tumor cross-sections were obtained from nonirradiated P7NP and P7NPH1 mice. Tumor hypoxia was evaluated with EF5 and tumor perfusion was evaluated with Hoechst. Hypoxia levels in both tumors from P7NP and P7NPH1 mice ranged from low to high (Fig. 3I-L) . Furthermore, there was no difference between the range of hypoxic content between tumors from P7NP and P7NPH1 mice (Fig. 3M) . This suggests that the tumor hypoxic content varies, and the loss of HIF-1a does not alter the presence of tumor hypoxia in this mouse model of primary soft tissue sarcoma. (22), we did not observe a significant difference in time to tumor initiation after 4-OHT injection (Fig. 4A ) or tumor growth (Fig. 4B ) between sarcomas in P7NP and P7NPH1 mice. To investigate the impact of deleting HIF-1a in tumor cells on radiation response of primary sarcomas, we generated a separate cohort of sarcomas in P7NP and P7NPH1 littermate mice. When these tumors reached approximately 200 mm 3 , we used image-guided radiation to deliver 5 daily fractions of 10 Gy. After irradiation, these tumors were followed for 180 days or until the tumors tripled from their initial volume at the time of the first dose of radiation. P7NP sarcomas (n ¼ 20) recurred between 2-50 days after the last dose of radiation, in contrast, P7NPH1 sarcomas (n ¼ 22) did not start to recur until 40 days after irradiation with 13.6% surviving to 180 days without any evidence of tumor recurrence (Fig. 4C) . Taken together, the data indicate that although HIF-1a has diverse targets that may play opposing roles in response to radiation (23), the overall effect of deleting HIF-1a in vivo in this mouse model of soft tissue sarcoma is radiosensitization.
Deletion of HIF-1a Sensitizes
The radiosensitization phenotype in P7NPH1 sarcomas in vivo may be dependent on tumor cell HIF-1a signaling within the tumor cells themselves (cell-autonomous) and/or through extracellular remodeling of tumor stroma (non-cellautonomous). To determine whether a cell-autonomous mechanism contributed to the radiosensitization phenotype of P7NPH1 sarcomas in vivo, we isolated tumor cells from nonirradiated P7NP and P7NPH1 mice and cultured them in vitro. After serial passaging the sarcoma cells to deplete stromal cells, we confirmed deletion of HIF-1a in the sarcoma cells by PCR as shown in Fig. 3A . Sarcoma cell proliferation rates were measured in vitro between the cell lines from P7NP and P7NPH1 mice by cell counting. There was no difference in sarcoma cell proliferation in vitro between the cell lines from P7NP and P7NPH1 mice (Fig.  4D) . Next, we assessed the impact of HIF-1a deletion on clonogenic survival of these cell lines after irradiation in vitro. We first assessed HIF-1a nuclear accumulation in cell cultures under 21% oxygen with P7NP cells by collecting nuclear protein lysates at 24 and 48 h after 6 Gy irradiation (Fig. 4E, inset) . Western blot analysis showed that there was already weak HIF-1a accumulation at 24 h after irradiation, which became prominent at 48 h after irradiation. This suggests that HIF-1a can accumulate in sarcoma cells under normoxia with radiation treatment in a time-dependent manner. When these sarcoma cells were exposed to increasing doses of radiation under normoxia, at all doses of radiation tested, P7NP sarcoma cells were more capable of forming colonies than P7NPH1 sarcoma cells (Fig. 4E) . The dose-modifying factor was calculated from these results to be 1.31 using methods as previously described (24) . To complement the clonogenic assay, we also measured apoptosis by staining for Annexin V and 7AAD. Because the difference in clonogenic survival between P7NP and P7NPH1 cells lines after 6 Gy irradiation was approximately fivefold (Fig. 4E) , this dose was selected for the apoptosis experiment. The percentage of Annexin Vpositive P7NPH1 cells was higher than P7NP cells 72 h after irradiation (Fig. 4F) , suggesting that the increase in apoptotic rate contributes to the increase in P7NPH1 sarcoma cell radiosensitivity. These results support a tumor cell-autonomous role for HIF-1a in promoting tumor cell survival after irradiation.
Deletion of HIF-1a Does Not Affect DNA Damage Repair, Cellular Reactive Oxygen Species (ROS) Response or Autophagy after Irradiation
Insufficient repair of radiation-induced DNA double-strand breaks can lead to increased cell death after irradiation. To determine if decreased DNA repair of P7NPH1 cells contributed to enhanced radiation sensitivity, we performed the comet assay (25) . To reduce the basal presence of the tail due to incompletely synthesized DNA strands, cells were cultured in normal media with 0.1% FBS to induce G 1 arrest. Arrested G 1 cells were 10 Gy irradiated under 21% oxygen conditions and collected at 0, 0.5, 1 and 4 h after exposure to measure the length of the comet tail. Both P7NP and P7NPH1 tumor cells had similar basal tail lengths without irradiation, and irradiation induced an increase in tail length (Fig. 5A) . After irradiation, the tail resolved with similar kinetics in P7NP and P7NPH1 cells, suggesting that cells with or without HIF-1a were able to repair DNA through non-homologous end joining with similar efficiency.
Radiation-induced ROS and subsequent ROS-related cellular damage can cause cell death after irradiation. Because the rate of repair for radiation-induced DNA damage was similar between P7NP and P7NPH1 cells (Fig. 5A) , radiation-induced ROS and subsequent clearance of ROS-induced adducts to cellular macromolecules HIF-1 ALPHA REGULATES SARCOMA RESPONSE TO RADIATION THERAPY FIG. 3 . HIF-1a deletion in sarcomas from P7NPH1 mice was efficient and did not change tumor subtype or degree of tumor hypoxia. Panels A-C: Primary cells from P7NP and P7NPH1 tumors were dissociated into single cell suspensions with tissue proteases and cultured deplete stromal cells. After 2-4 serial passages, primary tumor cells were collected to verify HIF-1a status by genomic DNA, RNA expression and protein expression. Panel A: Using primers specific for the HIF-1a conditional allele, the loxP flanked exon 2 of the Hif1a conditional allele was efficiently recombined (1-loxP) at the genomic level in sarcomas from P7NPH1 mice. Panel B: qRT-PCR specific for exon 2-containing HIF-1a mRNA transcript showed significant loss of expression in tumor cells from P7NPH1 mice when normalized to 18S by a two-tailed Student's t test. Panel C: Western blot using antibody against HIF-1a in denatured cell lysates from tumors in P7NPH1 mice showed no detectable HIF-1a protein in the nuclear protein extracts after culture under 0.5% oxygen for 16 h. Antibody probing against histone H3 served as nuclear protein loading control. Panels D-H: FFPE sections of primary P7NP and P7NPH1 tumors were H&E stained and scored as UPS or RMS by a pathologist blinded to the were examined to determine if they may contribute to the increased radiation sensitivity observed in P7NPH1 cells. To determine how the level of ROS accumulation changes in response to radiation, P7NP and P7NPH1 cells were first irradiated with 6 Gy. At 2, 24 and 72 h after irradiation, intracellular ROS was measured in both irradiated cells and nonirradiated controls by CellROXt Deep Red fluorescence by FACS. Intracellular accumulation of ROS was similar in P7NP and P7NPH1 cells at both 2 and 24 h after irradiation compared to baseline (Fig. 5B ) and this accumulation largely returned to baseline at 72 h after irradiation. Mitochondria-specific accumulation of superoxide was also examined using MitoSOXe fluorescence by FACS to further assess the intracellular ROS content after irradiation. Similar to CellROX measurements of total intracellular ROS after irradiation, P7NP and P7NPH1 cells have similar levels of mitochondrial superoxide generation at 2, 24 and 72 h after irradiation (Fig. 5C ). Because there was no difference in ROS accumulation either by measurement of total intracellular ROS or mitochondrial superoxide between P7NP and P7NPH1 cells after irradiation, accumulation of ROS does not appear to account for the increased radiosensitivity of P7NPH1 cells. Although P7NP and P7NPH1 cells accumulate similar levels of ROS after irradiation, P7NPH1 cells may be more sensitive to ROS-induced cellular damage due to defects in repairing and clearing of damaged cellular macromolecules. Oxygen radicals not only cause DNA damage, but they also cause damage to proteins and lipids (26, 27) . Oxidationmediated changes in proteins can be detected by proteincarbonyl adducts. To examine the extent of ROS-induced cellular damage in P7NP and P7NPH1 cells after irradiation, we assayed protein carbonylation as an indicator for cellular repair of ROS-mediated macromolecule damage. To do so, two of each P7NP and P7NPH1 primary sarcoma cell isolates were 6 Gy irradiated and protein lysates were collected at baseline and at 0.5, 24 and 72 h after irradiation. Western blotting for ROS-induced protein carbonylation and the quantifications of the bands in the lanes showed an immediate accumulation of protein carbonylation at 0.5 h after irradiation in both P7NP and P7NPH1 cells, which persisted at 24 h after irradiation (Fig. 5D) . However, protein carbonylation was resolving for some of the cell lines by 72 h after irradiation in both P7NP and P7NPH1 cells, indicated by a decrease in carbonyl group staining intensity in the first (P7NP tumor no.1) and fourth (P7NPH1 tumor no. 2) panels at 72 h. Together, these results indicate that P7NP and P7NPH1 sarcoma cells accumulate similar levels of ROS and ROSinduced protein damage after irradiation. Moreover, both P7NP and P7NPH1 cells resolve the ROS accumulation and ROS-induced damage after irradiation with similar kinetics. Thus, direct ROS-mediated effects do not appear to be the primary mechanism causing radiosensitivity in P7NPH1 cells.
Clearance of damaged cellular macromolecules depends on a functional autophagy pathway, but autophagy also has other functions including catabolism of nondamaged cellular components that may promote survival under stress (28, 29) . Thus, we examined possible defects in autophagy flux as a mechanism for radiation sensitization in P7NPH1 cells. During autophagy, LC3-I is modified to LC3-II on autophagosomes. Therefore, we assayed LC3A/B-I and LC3A/B-II accumulation by Western blot to measure autophagosome formation after irradiation. Whole cell lysates from P7NP and P7NPH1 cells were collected at baseline, 24 and 48 h after 6 Gy irradiation. LC3A/B-I and LC3A/B-II accumulation was normalized against actin. LC3A/B-II accumulated in a time-dependent manner after irradiation in both P7NP and P7NPH1 cells (Fig. 6 ). To determine if LC3A/B-II accumulation was due to an increase in autophagic flux or an inability to complete the autophagy pathway leading to the accumulation of autophagosomes, chloroquine was used to inhibit the progression of autophagic flux. Increased accumulation of LC3A/ B-II after chloroquine treatment (Fig. 6 ) indicated that both P7NP and P7NPH1 cells upregulated autophagic flux in response to radiation and there was no discernable difference in functional autophagic flux between P7NP and P7NPH1 cells. We also examined the accumulation of BECLIN1 and ATG3, two other important components of the autophagy pathway. Similar to LC3A/B-II accumulation after irradiation, BECLIN1 and ATG3 demonstrated tumor cell-line specific changes that were not dependent of HIF-1a status. These results suggest that differences in autophagic flux do not contribute significantly to the radiation sensitivity phenotype of P7NPH1 cells.
Deletion of HIF-1a Alters Metabolic Response after Irradiation
Because HIF-1a is known to regulate metabolic pathways and because changes in cellular metabolism may contribute to radiation sensitivity, we examined how deletion of HIF1a affects the metabolic response to radiation. We first assessed how intracellular lactate changed in response to radiation in P7NP and P7NPH1 cells using mass spectrometry (Fig. 7A) . This showed that while P7NP cells had increased lactate accumulation 24 h after 6 Gy irradiation, this accumulation was not evident in P7NPH1 cells. We also assessed the extracellular accumulation of lactate in the culture media after irradiation using a commercial lactate kit (Fig. 7B) . This showed that while extracellular lactate concentration was higher for P7NP cells compared to P7NPH1 cells at baseline and 2 h after irradiation, both P7NP and P7NPH1 cells had increased extracellular lactate by 24 h .   FIG. 6 . Deletion of HIF-1a did not affect changes in autophagy after irradiation. Primary cells from P7NP and P7NPH1 tumors were isolated as described in Fig. 3 . All experiments were performed with in vitro cultures under 21% oxygen. Cells were 6 Gy irradiated with and without adding 25 lM chloroquine 2 h prior to protein collection at the indicated times. Lysates were probed with an antibody against LC3A/B-I (top band) and LC3A/ B-II (bottom band) to measure changes in autophagic flux, and BECLIN1 and ATG3 to measure other components of the autophagy pathway. Deletion of HIF-1a (P7NPH1) did not affect the changes in autophagic flux after irradiation.
HIF-1 ALPHA REGULATES SARCOMA RESPONSE TO RADIATION THERAPY
We then assessed oxygen consumption rates (OCR) of P7NP and P7NPH1 cells at baseline, 8, 24 and 72 h after irradiation (Fig. 7C-G ). Drugs were added at different times during the OCR measurement to define the contribution from different components of oxidative phosphorylation. Dimethyl sulfoxide (DMSO) was added first as a control because it was used as the vehicle for the other drugs. After generating baseline OCR measurements with and without the DMSO control, we added oligomycin (Oligo) to inhibit ATP synthase activity and measure the contribution of ATP synthesis to the OCR. Once the OCR stabilized after the addition of oligomycin, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) was added to cause dissociation of the proton gradient and uncouple the electron transport chain (ETC) from the proton gradient to measure the maximal capacity of the ETC. Finally, Anti A and Rot were added to inhibit the ETC to quantify residual OCR from nonmitochondrial sources. These experiments showed that at baseline, OCR measurements were similar between P7NP and P7NPH1 sarcoma cells (Fig. 7C) . Eight hours after 6 Gy irradiation, OCR decreased to a similar extent in both P7NP and P7NPH1 cells, indicating radiation-induced inhibition of mitochondrial oxidative phosphorylation (Fig. 7D) . At 24 h after 6 Gy irradiation, FIG. 7 . Loss of HIF-1a was correlated with metabolic changes in sarcoma cells in response to radiation. Primary cells from P7NP and P7NPH1 tumors were isolated as described in Fig. 3 . All experiments were performed with in vitro cultures under 21% oxygen. Panel A: Cells were 6 Gy irradiated and lysates were collected at the indicated times after irradiation, and intracellular lactate was measured with mass spectrometry. The results showed P7NP cells had significantly increased intracellular lactate content at 24 h after irradiation, both compared to nonirradiated P7NP cells and P7NPH1 cells by a two-tailed Student's t test. Panel B: Cells were 6 Gy irradiated and lysates were collected at the indicated times after irradiation, and extracellular lactate was measured with the lactate colorimetric kit. The results showed P7NP cells had significantly increased extracellular lactate content at 0 and 2 h after irradiation compared to P7NPH1 cells by a two-tailed Student's t test. Panels C-G: Oxygen consumption rates (OCR) were measured in cells that were 6 Gy irradiated at indicated times after exposure. DMSO, oligomycin (Oligo), FCCP, antimycin A (Anti A), rotenone (Rot) and 2-deoxyglucose P7NPH1 cells regained baseline ETC activities while those of P7NP cells were still defective, as shown by differences in OCR after FCCP administration (Fig. 7E) . Furthermore, P7NPH1 cells had increased reserve capacity compared to P7NP cells at 24 h after irradiation. The ETC defect of P7NP cells was restored by 72 h after irradiation (Fig. 7F) . The OCR results suggest that at 24 h after irradiation, although the baseline OCR was similar between P7NP and P7NPH1 cells, P7NPH1 cells may have increased flux or accumulation of ETC substrates such as NADH or succinate that result in increased maximal oxygen consumption and reserve capacity after FCCP-mediated ETC and ATP synthase dissociation. Taken together, these results further support that P7NP and P7NPH1 cells elicit different metabolic changes 24 h after irradiation. To determine the metabolic source of ETC activity, P7NP and P7NPH1 cells were irradiated and OCR was measured 24 h later, but instead of using Anti A and Rot to inhibit the ETC at the final step, 2-deoxyglucose (2-DG) was added to inhibit the glycolytic pathway at the level of hexokinase (Fig. 7G) . Addition of 2-DG did not significantly inhibit OCR generated by the ETC after FCCP administration in either P7NPH1 or P7NP cells, suggesting that glucose was not the source for increased ETC substrate in P7NPH1 cells at 24 h after irradiation.
Deletion of HIF-1a Alters Mitochondrial Density after Irradiation
Because we observed metabolic changes in HIF-1a-deficient sarcoma cells after irradiation, we assessed mitochondrial density in P7NP and P7NPH1 cells by measuring mitochondrial mass before and after irradiation using flow cytometry with MitoTrackert Deep Red and mtDNA qRT-PCR. Using flow cytometry, we found that at 72 h after irradiation, P7NP cells had a significantly higher mitochondrial mass than P7NPH1 cells (Fig. 8A) . Similarly, P7NP cells with intact HIF-1a had increased mtDNA content when measured by qPCR compared to P7NPH1 cells 72 h after irradiation (Fig. 8B) . These results show that HIF-1a-wild-type and -deficient sarcoma cells regulate mitochondrial biogenesis differentially after irradiation and this may play a role in the observed radiation sensitivity in HIF-1a-deficient cells.
Knockdown of Hif-1a in P7NP Sarcoma Cells Causes Radio-Sensitization and a Mitochondrial Biogenesis Defect after Irradiation
We next tested whether the radiosensitization and mitochondrial biogenesis defect after irradiation in P7NPH1 sarcoma cells could be recapitulated in P7NP sarcoma cells stably expressing a shRNA to Hif-1a. First, we assessed the degree of Hif-1a knockdown in sarcoma cells isolated from three individual P7NP primary tumors after culturing in 0.5% oxygen for 24 h. We showed that after Hif-1a knockdown, the level of residual HIF-1a nuclear protein was reduced to below the level of detection by Western blot (Fig. 9A) . After confirming successful depletion of HIF-1a protein in P7NP sarcoma cells, we irradiated parental P7NP sarcoma cells and corresponding Hif-1a knockdown daughter cells with 6 Gy and assessed The mitochondrial DNA (mtDNA) content was measured via real-time PCR using DNA extracted from purified P7NP and P7NPH1 sarcoma cells at 72 h after 6 Gy irradiation, and normalized to 18S and nonirradiated controls. P7NP cells had more mtDNA content at 72 h after irradiation compared to P7NPH1 cells by a twotailed Student's t test. *P , 0.05 and **P , 0.01.
HIF-1 ALPHA REGULATES SARCOMA RESPONSE TO RADIATION THERAPY clonogenic survival. Similar to the radiation response of P7NPH1 cells, P7NP cells with Hif-1a knockdown also demonstrated increased sensitization to radiation compared to P7NP controls (Fig. 9B) . Additionally, P7NP cells with knockdown of Hif-1a also had significantly decreased mtDNA content when measured by qPCR compared to the parental P7NP controls at 72 h after 6 Gy irradiation (Fig.  9C) . These results further support a role for HIF-1a in mediating resistance of sarcoma cells to radiation in a cellautonomous manner, which is associated with an increase in mitochondrial biogenesis after irradiation.
DISCUSSION
Intratumoral hypoxia causes radiation resistance in a number of cancers including soft tissue sarcomas (30) (31) (32) (33) . Molecular oxygen promotes radiation sensitivity by reacting with DNA radicals to create adducts that are difficult for the cell to repair, which leads to increased cell death. Thus, under hypoxic conditions, ionized DNA is more easily repaired and cells are more likely to survive. In addition, hypoxia activates signaling pathways, such as HIFs, which may also contribute to radiation resistance. In this scenario, these signaling pathways could be targeted to sensitize hypoxic tumors. In addition, HIF-1a is activated by radiation (34) and chemotherapy (35) even under normoxic conditions. Indeed, we observed increased expression of HIF-1a in human soft tissue sarcomas after interdigitated chemotherapy and radiation therapy. Therefore, such survival pathways may also regulate tumor response in normoxic tumors. Previous studies using transplanted model systems have implicated HIF-1a in radiation resistance via non-cell autonomous mechanisms (11, 12, 36) . For example, activation of HIF-1a in tumor cells increase secretion of cytokines such as VEGF, which promotes survival of tumor endothelial cells (11) . Moreover, after   FIG. 9 . Knockdown of HIF-1a sensitizes P7NP cells to radiation and leads to a radiation-induced mitochondrial biogenesis defect. Primary cells from P7NP tumors were isolated as described in Fig. 3 . All experiments were performed with in vitro cultures under 21% oxygen. Panel A: Efficiency of Hif-1a knockdown by shRNA was measured by measuring HIF-1a protein level in nuclear extracts of parental P7NP sarcoma cells and P7NP cells stably expressing Hif-1a shRNA cultured under 0.5% oxygen for 24 h. This showed that the efficiency of Hif-1a knockdown in P7NP sarcoma cells obtained from three different tumors was beyond the level of detection by Western blot. Panel B: Knockdown of Hif-1a by shRNA resulted in significantly increased radiation sensitivity compared to the parental controls after exposure to 6 Gy under 21% oxygen when measured by clonogenic survival, by a two-tailed Student's t test. Each symbol represents a parental control P7NP cells and its corresponding knockdown daughter sarcoma cells. Panel C: The mitochondrial DNA (mtDNA) content was measured via real-time PCR using DNA extracted from parental P7NP and P7NP cells with Hif-1a knockdown at 72 h after 6 Gy irradiation and normalized to 18S. P7NP cells had more mtDNA content at 72 h after irradiation compared to P7NP cells with Hif-1a shRNA, by a two-tailed Student's t test. Each symbol represents a parental control P7NP and its corresponding knockdown daughter sarcoma cells. *P , 0.05 and **P , 0.01. radiation therapy HIF-1a can also increase the expression of SDF1, which recruits bone marrow-derived macrophages to tumors to promote vasculogenesis and tumor regrowth (36) . However, the role of HIF-1a in mediating the response of primary cancers to radiation therapy had not previously been investigated.
In our study, we generated a novel primary mouse model of soft tissue sarcoma expressing oncogenic NRAS with p53 deletion that resembles human RMS and UPS. Other studies including those from our group (15, 37) have shown that by introducing driver mutations in PAX7-expressing adult skeletal muscle stem cells, primary soft tissue sarcomas develop in a continuum of RMS and UPS, suggesting that these entities may be more similar than previously anticipated.
We then deleted HIF-1a in the tumor cells of these sarcomas at the time of sarcoma initiation. Complete deletion of HIF-1a was confirmed by PCR for recombination of the genomic Hif-1a FL DNA, qRT-PCR for the exon 2-containing Hif-1a transcript, and by Western blot for HIF1a protein in stroma-depleted tumor cells. Deletion of HIF1a in sarcomas in P7NP mice did not affect the timing of sarcomagenesis or sarcoma growth kinetics. However, sarcomas lacking HIF-1a in the tumor cells were more sensitive to 50 Gy of fractionated radiation treatment (10 Gy 3 5) in vivo. Although five fractions of radiation treatment may not recapitulate the most frequently used radiation therapy schedule for soft tissue sarcomas, it is still clinically relevant, since emerging evidence suggests that hypofractionation with five fractions may have similar rates of local control and toxicity profiles (38) . Moreover, sarcoma cells lacking HIF-1a by either genomic ablation or shRNA knockdown were also sensitized to radiation in vitro by clonogenic assays. Taken together, these results indicate that in addition to non-cell autonomous mechanisms, HIF1a can promote radiation resistance in primary cancers through cell autonomous mechanisms.
A number of cell autonomous pathways can regulate the response of tumor cells to radiation including ROS scavenging, autophagy and DNA damage repair (39) (40) (41) . However, when we examined these pathways in sarcoma cells with an intact or deleted HIF-1a, no significant differences in these pathways were observed after irradiation in 21% oxygen in vitro. These results suggest that under these conditions, HIF-1a does not promote radiation resistance through these cell autonomous pathways. However, these results do not exclude the possibility that under hypoxic conditions or in vivo, these pathways could contribute to HIF-1a-mediated resistance to radiation treatment.
In contrast, when we measured mitochondrial density and changes in oxidative phosphorylation after irradiation, we found that consistent with previous studies (42, 43) , after 6 Gy irradiation sarcoma cells with an intact HIF-1a increased their mitochondrial density and decreased their mitochondrial oxidative phosphorylation. However, sarcoma cells without HIF-1a did not increase their mitochondrial density and recovered mitochondrial respiration much more quickly after irradiation. Furthermore, this result was recapitulated by irradiating sarcoma cells with successful Hif-1a knockdown by shRNA. These results suggest that HIF-1a regulates mitochondrial respiration and density after irradiation, which is one potential cell autonomous mechanism that may contribute to radiation resistance. Future studies will seek to identify HIF-1a transcriptional targets that regulate mitochondrial respiration and density after irradiation. If these pathways do contribute to radiation resistance, then they may provide therapeutic targets to sensitize tumors to radiation therapy.
In summary, we have established a novel mouse model of soft tissue sarcoma in which deletion of HIF-1a increases the sensitivity of tumors to fractionated radiation treatment in vivo. In this novel study we show that deletion of HIF-1a increased the sensitivity of cancer to radiation treatment in an autochthonous tumor model. Moreover, we found that sarcoma cells lacking HIF-1a are more sensitive to radiation in vitro with a dose-modifying factor of 1.31. Therefore, HIF-1a promotes radiation resistance via cell autonomous mechanisms, which may include altering mitochondrial metabolism. Identifying HIF-1a targets that regulate the response of mitochondria to radiation treatment may identify novel pathways that regulate radiation resistance, which could then be targeted to improve radiation sensitivity. Table S1 . Western blot, immunofluorescence, immunohistochemistry and fluorescence-activated cell sorting reagents.
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